The TroFuse-005 trial involved 776 patients with endometrial cancer whose disease worsened after receiving both platinum ...

The TROP2-directed antibody-drug conjugate demonstrated superior efficacy over physician’s choice of chemotherapy in patients previously treated with platinum-based therapy and immunotherapy.

Merck MRK announced that the pivotal phase III TroFuse-005 study, which evaluated its pipeline candidate, sacituzumab ...

May 18 (Reuters) - Merck said on Monday its experimental drug met the main goals of a late-stage trial in patients with a ...

Merck's TroFuse-005 Trial Evaluating Sac-TMT Met Primary Endpoints of OS and PFS in Certain Patients With Advanced or ...

The TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) demonstrated a statistically significant ...

She was the most outgoing caring person in the world in September 2020. At the age of 63 Sherlyn Webb was diagnosed with uterine cancer but was told the disease had been caught early. We thought that ...

After receiving radiation therapy for uterine cancer, you may experience fertility challenges, vaginal dryness, and bowel or bladder problems. Options to manage and relieve your side effects can vary.

Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for ...

Common early uterine cancer symptoms include atypical vaginal bleeding (including after menopause), unusual vaginal discharge, and pelvic pain. The condition is most common in females above 50 years ...

Inside your pelvis is an organ that plays an important role in your period, ability to get pregnant, and carry a pregnancy. As with other parts of your body, sometimes cancer cells can grow there. The ...